Top Story

1:11 pm

TSX halts 7-day rout as China fears abate; Husky, MEG gain

Canadian shares broke a seven-day rout as investors assessed earnings reports and as Chinese shares pulled back from a selloff. The Standard & Poor’s/TSX Composite Index (TSE:OSPTX) rose 0.4 percent to 14,053.12 at 12:50 p.m. in Toronto. Three shares advanced for every issue that declined as six out of ten share groups were in the positive territory.

Breaking News

oilgas180x120.png

Tuesday, July 28, 1:17 pm

The Obvious Trade That The Entire Market Has Missed

It is as plain as the nose on your face but it has been missed by virtually everyone, especially the analyst community. Yesterday (Monday) was the first time I saw an energy analyst on TV talking a...

International

11:40 am

RSA Insurance shares soar as rival Zurich mulls bid

Move may herald mergers as insurers beef up funds amid new solvency rules

Articles

  • Lawsuits and tough competition are driving American Apparel toward bankruptcy

    The stock price has lost over 20% in the past 24 hours as ‘The New Yorker’ asked in an article published on July 27 whether the company could afford to maintain its production in the United States

  • Wall Street on track to end 5-day rout as China selloff stalls

    Wall Street is poised to end a five-session losing streak, amid better-than-forecast earnings, as Chinese equities pulled back from a selloff, and ahead of a highly anticipated Federal Reserve meeting. Futures for the Dow Jones Industrial Average rose 0.4 percent to 17,460, while those for the S&P 500 index added 0.4 percent to 2,073. Futures for the Nasdaq 100 index picked up 0.3 percent to 4,536.25.

  • Teva to buy Allergan for $40.5 bln, drops Mylan bid

    Teva Pharmaceutical Industries (NYSE:TEVA), an Israeli drugmaker, agreed to buy Dublin-based Allergan PLC's (NYSE:AGN) generic pharmaceuticals business for $40.5 billion in cash and stock, and dropped its hostile offer for Mylan (NASDAQ:MYL). Teva will pay $33.75 billion in cash and $6.75 billion worth of shares at today’s price, or about 10 percent of the enlarged company, the Petach Tikva, Israel-based company said in a statement today. 

  • GlaxoSmithKline receives EU approval of its malaria fighting vaccine for children

    Approval from the EMA opens the door for a similarly favorable opinion from the World Health Organization (WHO), which could then decide whether to recommend vaccination in countries where malaria is endemic

  • Lithium – the metal of the future (if there's enough)

    Tesla is not alone in advancing lithium-powered battery technologies. 

    It’s headline-grabbing stuff - Elon Musk says that his Tesla Corporation (NASDAQ:TSLA) aims to accelerate technological and market development by up to ten years in the roll-out of electric cars.

  • Amazon.com swings to surprise Q2 profit, provides robust Q3 revenue guidance

    Amazon.com (NASDAQ:AMZN), an online retailer, reported an unexpected second-quarter profit, forecast third-quarter revenue above estimates, and reported strong sales in North America, and unprecedented growth in its popular Prime two-day unlimited shipping service. Shares surged.

Archived Top Stories ►
  • Energy Fuels emerging as the major US uranium player

    Curtis Moore, vice president of Energy Fuels (TSE:EFR) (NYSE:UUUU), says the company is emerging as the major uranium producer in the United...
    View full size
  • Gold facing ‘perfect storm’ says CMC Markets’ Cieszynski

    Colin Cieszynski, chief market strategist at CMC Markets, explains why he believes gold is facing a perfect storm in the current environment,...
    View full size
  • VolitionRX seeks to revolutionise cancer diagnosis Share

    New York-listed VolitionRx aims to revolutionise cancer screening, and its chief executive Cameron Reynolds explains to Proactive Investors...
    View full size
  • Greencastle Resources CEO outlines royalty strategy

    Tony Roodenburg, chief executive of Greencastle Resources (CVE:VGN), discusses the company’s strategy with Proactive Investors and explains...
    View full size
  • PDAC 2015 presentations: Endeavour Silver

    Terry Chandler, vice president of corporate development at Endeavour Silver (NYSE:EXK, TSE:EDR), explains his plans for the company at the...
    View full size
  • PDAC 2015 presentations: Arian Silver

    Jim Williams, chief executive of Arian Silver (LON:AGQ, CVE:AGQ), talks investors through the strategy at the PDAC Power Breakfast 2015.
    View full size
  • PDAC 2015 presentations: Largo Resources

    Mark Brennan, president, chief executive and director of Largo Resources (CVE:LGO), presents to investors at the PDAC Power Breakfast 2015.
    View full size
  • Canadian Overseas Petroleum CFO on ‘significant’ tie-up with Shoreline Energy

    Christopher McLean, the chief financial officer of Canadian Overseas Petroleum (LON:COPL), explains the benefits of teaming up with Shoreline...
    View full size
  • Mandalay Resources unveils positive Q4 figures

    Record production in its fourth quarter helped gold and silver miner Mandalay Resources (TSE:MND) lift fourth quarter profits despite weak...
    View full size
  • ANGLE CEO: Fully funded for Parsortix ovarian cancer care, new partnership with MD Anderson

    Andrew Newland, the chief executive of ANGLE plc (LON:AGL) spoke about the need for speed to progress the firm’s plans to revolutionise...
    View full size
  • Rathdowney Resources is the Next Zinc Producer in Europe

    Interview with Chairman & Director David Copeland
    View full size
  • Rathdowney Resources is Moving Straight Forward for the Permitting of the Olza Deposit

    Interview with President & CEO Robert Konski - Commodity TV
    View full size